z-logo
open-access-imgOpen Access
Activation of Nrf2-Regulated Glutathione Pathway Genes by Ischemic Preconditioning
Author(s) -
Karen Bell,
Jill H. Fowler,
Bashayer AlMubarak,
Karen Horsburgh,
Giles E. Hardingham
Publication year - 2011
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2011/689524
Subject(s) - neuroprotection , glutathione , endogeny , oxidative stress , in vivo , transcription factor , pharmacology , mediator , microbiology and biotechnology , ischemia , ischemic preconditioning , biology , chemistry , gene , biochemistry , medicine , enzyme , genetics
Prophylactic pharmacological activation of astrocytic gene expression driven by the transcription factor Nrf2 boosts antioxidant defences and protects against neuronal loss in ischemia and other disease models. However, the role of Nrf2 in mediating endogenous neuroprotective responses is less clear. We recently showed that Nrf2 is activated by mild oxidative stress in both rodent and human astrocytes. Moreover, brief exposure to ischemic conditions was found to activate Nrf2 both in vivo and in vitro , and this was found to contribute to neuroprotective ischemic preconditioning. Here we show that transient ischemic conditions in vitro and in vivo cause an increase in the expression of Nrf2 target genes associated with the glutathione pathway, including those involved in glutathione biosynthesis and cystine uptake. Taken together, these studies indicate that astrocytic Nrf2 may represent an important mediator of endogenous neuroprotective preconditioning pathways.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom